Scientific Director, Coalition to Cure Calpain 3
United States of America
Dr. Levy is the Scientific Director at Coalition to Cure Calpain 3 (C3) where she facilitates research into finding treatments for LGMDR1 by managing the grant program and by interacting with international experts in muscular dystrophy research, including those in academia, bio-pharmaceutical companies, government, and peer organizations.
Previously, Dr. Levy was a member of Dr. Kevin Campbell’s laboratory at the Howard Hughes Medical Institute and the University of Iowa where she performed postdoctoral research on the roles of the ubiquitous calpains in skeletal muscle function. She has co-authored multiple peer-reviewed manuscripts, and her research has been supported by grants from the National Institutes of Health and a development grant from the Muscular Dystrophy Association. Dr. Levy earned her PhD in Cell and Molecular Biology at the University of Pennsylvania and her BS in Molecular and Cell Biology from the University of Connecticut.